Literature DB >> 34865445

[Progress and prospect of the treatment of lower extremity arteriosclerosis obliterans].

Y H Zheng1, X T Song1.   

Abstract

In the past five years,both advancements and new problems were seen in the treatment of lower extremity arteriosclerosis obliterans.The Global Vascular Guidelines published in 2019 have given us comprehensive suggestions for the diagnosis and treatment of critical limb threatening ischemia(CLTI),but the grading and treatment suggestions for CLTI should be generalized.As to endovascular treatment,drug coated balloons have been found to be effective for limb salvage and graft patency in femoropopliteal and infra-popliteal artery occlusive diseases.As to surgical revascularization,persistent education and surveillance are necessary to maintain the practical quality of this fundamental technique.Inframalleolar bypass could achieve good graft patency and limb salvage rate for in CLTI patients.Regional anesthesia has been found to have lower risk than general anesthesia for lower extremity surgical revascularization.Percutaneous deep vein arterialization might be helpful for limb salvage in patients with non-option CLTI.A brief review about the treatment of lower extremity arteriosclerosis obliterans is performed based on latest literatures and institutional experience.Understanding the present situation and development trend is important for peripheral vascular practitioners.

Entities:  

Mesh:

Year:  2021        PMID: 34865445     DOI: 10.3760/cma.j.cn112139-20210923-00453

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  4 in total

1.  Efficacy and Safety Differences between Domestic Paclitaxel Drug-Coated Balloons and Metal Bare Stents in the Treatment of ASO of Femoral-Popliteal Arteries Type IIA-C.

Authors:  Fuqing Wei; Fenglei Huang; Fengkui Cui
Journal:  Contrast Media Mol Imaging       Date:  2022-07-06       Impact factor: 3.009

2.  Ultrasonic Image Feature Analysis under Deep Learning Algorithm to Evaluate the Efficacy of Drug-Coated Balloon for Treatment of Arteriosclerotic Occlusion.

Authors:  Yuchao Zhang; Gang Xu; Maozhen Chen; Ziliang Chen; Mingyang Shen; Ping Wang
Journal:  Comput Math Methods Med       Date:  2022-05-31       Impact factor: 2.809

3.  Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.

Authors:  Deshuang Xiao; Jun Song
Journal:  Comput Math Methods Med       Date:  2022-08-04       Impact factor: 2.809

4.  Effects of Drug-Coated Balloon Therapy on CT Imaging Results and Levels of Vascular Inflammatory Cytokines in Patients with Arteriosclerosis Obliterans Lesions.

Authors:  Yanlin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-22       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.